Literature DB >> 18288929

Pro-inflammatory cytokines modulate glial apolipoprotein E secretion.

Rosanne Aleong1, Jean-Francois Blain, Judes Poirier.   

Abstract

Alzheimer's disease (AD) is a neurological disorder characterized by plaques and an elevated immune response. Specifically, increased expression of interleukin (IL)-1 and tumour necrosis factor (TNF)-alpha, has been observed in AD cerebrospinal fluid and temporal brain tissue. Both of these immunomodulators were shown to carry genetic variants that increase the risk of developing AD. Studies have also established the apolipoprotein E (apoE) gene to be a risk factor for AD with epsilon4 carriers having been found to show lower levels of brain apoE. In the present study, treatment of primary rat mixed glial cell cultures with IL-1beta induced a significant increase in extracellular apoE protein. In contrast, treatment primary rat astrocyte and mixed glial cell cultures with TNF-alpha significantly reduced extracellular apoE protein levels. These results are consistent with the notion that elevated cytokine expression directly modulates immunosuppression and indirectly apoE-mediated neuronal remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288929     DOI: 10.2174/156720508783884666

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  10 in total

Review 1.  Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.

Authors:  Evan Dorey; Nina Chang; Qing Yan Liu; Ze Yang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

Review 2.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

3.  Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena.

Authors:  Yan Ji; Xiaowan Wang; Colin Kalicki; Blaise W Menta; Megan Baumgardner; Scott J Koppel; Ian W Weidling; Judit Perez-Ortiz; Heather M Wilkins; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

Review 5.  An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease.

Authors:  Blaise W Menta; Russell H Swerdlow
Journal:  Neurochem Res       Date:  2018-08-06       Impact factor: 3.996

6.  Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.

Authors:  David Tweedie; Ryan A Ferguson; Kelly Fishman; Kathryn A Frankola; Henriette Van Praag; Harold W Holloway; Weiming Luo; Yazhou Li; Luca Caracciolo; Isabella Russo; Sergio Barlati; Balmiki Ray; Debomoy K Lahiri; Francesca Bosetti; Nigel H Greig; Susanna Rosi
Journal:  J Neuroinflammation       Date:  2012-05-29       Impact factor: 8.322

7.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

Review 8.  Cross-talk between apolipoprotein E and cytokines.

Authors:  Hongliang Zhang; Li-Min Wu; Jiang Wu
Journal:  Mediators Inflamm       Date:  2011-06-28       Impact factor: 4.711

9.  Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation.

Authors:  Maria Fe Lanfranco; Jordy Sepulveda; Gregory Kopetsky; G William Rebeck
Journal:  Glia       Date:  2021-02-08       Impact factor: 8.073

10.  ApoE production in human monocytes and its regulation by inflammatory cytokines.

Authors:  Sten Braesch-Andersen; Staffan Paulie; Christian Smedman; Sohel Mia; Makiko Kumagai-Braesch
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.